CERo Therapeutics Holdings Inc
CERO7.640USD
-0.035-0.46%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
7.640USD+7.640After-hours (ET)
1.97MMarket Cap
LossP/E TTM
CERo Therapeutics Holdings Inc
7.640
-0.035-0.46%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
Total equity
Cash, cash equivalents and short-term investments
13.29%5.20M
--3.33M
--3.38M
--3.65M
--4.59M
- Cash and cash equivalents
13.29%5.20M
--3.33M
--3.38M
--3.65M
--4.59M
Receivables
----
----
----
--87.43K
--162.06K
-Other receivables
----
----
----
--87.43K
--162.06K
Prepaid expenses
-24.34%564.46K
--274.75K
--334.28K
--511.46K
--746.04K
Other current assets
----
--112.23K
----
----
----
Total current assets
4.85%5.77M
--3.71M
--3.71M
--4.25M
--5.50M
Non-current assets
Net Fixed Assets
-39.91%1.72M
--1.99M
--2.28M
--2.57M
--2.87M
-Fixed Assets
-16.28%3.83M
--4.02M
--4.21M
--4.39M
--4.57M
-Accumulated depreciation
23.56%2.10M
--2.03M
--1.93M
--1.82M
--1.70M
Other non-current assets
-26.83%500.00K
--612.23K
--500.00K
--550.00K
--683.35K
Total non-current assets
-37.39%2.22M
--2.49M
--2.78M
--3.12M
--3.55M
Total assets
-11.72%7.99M
--6.21M
--6.49M
--7.37M
--9.05M
Liabilities
Current liabilities
-Dividends payable
--85.50K
--85.50K
----
----
----
-Other payables
-99.37%20.00K
--961.60K
--61.07K
--225.60K
--3.19M
Accrued expenses
-3.45%194.53K
--1.91M
--1.66M
--1.13M
--201.47K
Short-term debt and lease liabilities
----
----
--102.27K
--253.17K
--402.51K
-Short-term debt
----
----
--102.27K
--253.17K
--402.51K
Other current liabilities
-99.37%20.00K
--961.60K
--61.07K
--225.60K
--3.19M
Total current liabilities
-32.55%7.86M
--7.40M
--9.42M
--8.78M
--11.65M
Non-current liabilities
Long-term debt and lease liabilities
-66.22%461.58K
--699.11K
--771.52K
--1.07M
--1.37M
-Long-term lease liabilities
-66.22%461.58K
--699.11K
--771.52K
--1.07M
--1.37M
Other non-current liabilities
----
----
----
----
--13.72K
Total non-current liabilities
-66.56%461.58K
--699.11K
--771.52K
--1.07M
--1.38M
Total liabilities
-36.15%8.32M
--8.10M
--10.19M
--9.85M
--13.03M
Shareholders' equity
Common equity
35.83%73.35M
--67.14M
--66.38M
--57.64M
--54.00M
Retained earnings
-17.12%-76.02M
---70.92M
---71.59M
---67.36M
---64.91M
Capital reserves
35.84%73.35M
--67.14M
--66.36M
--57.63M
--53.99M
Total equity
91.72%-329.39K
---1.89M
---3.70M
---2.48M
---3.98M
Currency unit
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
